Schedule 13D ownership disclosure
SUNESIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 867328502
Event date: 2015-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000512
- Form type
- SC 13D
- Filer
- New Enterprise Associates 12, Limited Partnership
- CIK
- CIK 1383391
- Filed
- Jan 07, 2016
- Reporting period
- Dec 21, 2015
- Description
- Schedule 13D beneficial ownership